10 DRUG PANELS • MDMA & BUP • HIGH-CUTOFF OPI/2000 • 120 mL
10-Panel MDMA, Buprenorphine & High-Cutoff Opiate Multi-Drug Urine Test Cup
Comprehensive preliminary urine drug screening with dedicated MDMA, buprenorphine and OPI/2000 panels.
This self-contained 120 mL urine drug test cup screens for amphetamines, buprenorphine, benzodiazepines, cocaine, MDMA, methamphetamine, methadone, opiates, oxycodone and marijuana.
The configuration combines a high-cutoff OPI/2000 panel with separate BUP, MTD and OXY panels for broader opioid-related screening. Collection, temperature verification and preliminary testing take place in one convenient cup, with results available in approximately five minutes.
Product Highlights
Ten-Drug Screening Screens for AMP, BUP, BZO, COC, MDMA, MET, MTD, OPI, OXY and THC.
Dedicated MDMA Panel Screens for MDMA or ecstasy at the manufacturer-listed 500 ng/mL cutoff.
Dedicated Buprenorphine Panel Screens for buprenorphine at the listed 10 ng/mL cutoff.
High-Cutoff OPI/2000 Screens morphine and related opiates at the listed 2,000 ng/mL cutoff.
Expanded Opioid Coverage Includes separate BUP, MTD, OPI and OXY screening panels.
Results in Minutes Provides clear preliminary results in approximately five minutes.
One-Step Testing Collection and preliminary screening are completed using one integrated device.
Large 120 mL Capacity Provides ample specimen capacity for convenient urine collection.
Leak-Resistant Lid Secure no-drip twist closure helps reduce leakage and accidental spills.
Built-In Temperature Strip Supports prompt verification that specimen temperature is within the expected range.
Manufacturer-Stated Accuracy Manufacturer information reports up to 99% accuracy when used as directed.
Same-Day Shipping Eligible orders placed within the applicable processing window ship the same business day.
Ten Drug Panels with MDMA, Buprenorphine and High-Cutoff OPI/2000 Screening A practical solution for healthcare facilities, occupational health clinics, treatment programs, rehabilitation centers, collection sites, correctional settings and authorized workplace screening.
Drug Panels and Cutoff Levels
Review the ten drug categories and manufacturer-listed preliminary screening cutoff levels.
| TEST STRIP |
TESTED DRUG |
ESTIMATED DETECTION TIME / CUTOFF |
|
AMP AMP AMP AMP AMP AMP AMP AMP AMP AMP
|
Amphetamines |
1–2 Days • 1,000 ng/mL |
|
BUP BUP BUP BUP BUP BUP BUP BUP BUP BUP
|
Buprenorphine |
2–6 Days • 10 ng/mL |
|
BZO BZO BZO BZO BZO BZO BZO BZO BZO BZO
|
Benzodiazepines |
1–2 Days • 300 ng/mL |
|
COC COC COC COC COC COC COC COC COC COC
|
Cocaine |
2–4 Days • 300 ng/mL |
|
MDMA MDMA MDMA MDMA MDMA MDMA MDMA MDMA
|
MDMA / Ecstasy |
2–4 Days • 500 ng/mL |
|
MET MET MET MET MET MET MET MET MET MET
|
Methamphetamine |
2–4 Days • 1,000 ng/mL |
|
MTD MTD MTD MTD MTD MTD MTD MTD MTD MTD
|
Methadone |
1–3 Days • 300 ng/mL |
|
OPI OPI OPI OPI OPI OPI OPI OPI OPI OPI
|
Morphine / Opiates |
2–3 Days • 2,000 ng/mL |
|
OXY OXY OXY OXY OXY OXY OXY OXY OXY OXY
|
Oxycodone |
1–3 Days • 100 ng/mL |
|
THC THC THC THC THC THC THC THC THC THC
|
Marijuana |
15–30 Days • 50 ng/mL |
Please Note: Detection windows vary according to dosage, frequency of use, metabolism, hydration, body composition, specimen concentration and other individual factors. Refer to the manufacturer’s package insert for exact cutoff levels, cross-reactivity information and interpretation instructions.
High-Cutoff OPI/2000 Screening The opiate panel uses a manufacturer-listed preliminary screening cutoff of 2,000 ng/mL. It is separate from the dedicated buprenorphine, methadone and oxycodone panels.
Separate BUP, MTD, OPI and OXY Panels Buprenorphine, methadone and oxycodone may not be detected with equal sensitivity by a traditional opiate panel. Dedicated panels provide targeted preliminary screening for each listed analyte.
Dedicated MDMA Screening The MDMA panel screens for ecstasy-related compounds identified in the manufacturer’s package insert at the listed 500 ng/mL cutoff.

How to Use the 10-Panel MDMA, Buprenorphine & High-Cutoff Opiate Multi-Drug Urine Test Cup

Understanding the 10-Panel MDMA, Buprenorphine & High-Cutoff Opiate Multi-Drug Urine Test Cup Results

Product Dimensions and Specifications
| 10-Panel MDMA, Buprenorphine & High-Cutoff Opiate Drug Test Cup |
| Drug panels |
AMP, BUP, BZO, COC, MDMA, MET, MTD, OPI, OXY and THC |
| Buprenorphine cutoff |
BUP/10 |
| MDMA cutoff |
MDMA/500 |
| Methadone cutoff |
MTD/300 |
| Opiate cutoff |
OPI/2000 |
| Oxycodone cutoff |
OXY/100 |
| Result time |
Approximately 5 minutes |
| Capacity |
120 mL |
| Height |
3.25 inches |
| Bottom width |
2 inches |
| Lid width |
2.63 inches |
| Approximate weight |
0.14 lb |
CLIA Waived and FDA 510(k) Cleared
According to the supplied manufacturer information, this exact 10-panel configuration is CLIA Waived and FDA 510(k) Cleared for the intended uses identified in its labeling. Verify the regulatory status printed on the exact product packaging before advertising or use.
What CLIA Waived Means Eligible point-of-care sites may use the test under a CLIA Certificate of Waiver when the manufacturer’s instructions and applicable requirements are followed.
What FDA 510(k) Cleared Means The device completed the applicable FDA premarket-clearance process for the intended uses identified in its authorized labeling.
Depending on its exact labeling and applicable requirements, this cup may be suitable for physician offices, occupational health clinics, treatment and rehabilitation programs, collection sites, probation and correctional programs, law-enforcement settings and qualifying workplace-screening programs.
Regulatory Notice: FDA clearance and CLIA-waived status are separate designations. State and local requirements may apply, and regulatory status can vary by exact cup configuration or individual assay.
Frequently Asked Questions
1. Which substances does this 10-panel cup screen for? It screens for amphetamines, buprenorphine, benzodiazepines, cocaine, MDMA, methamphetamine, methadone, opiates, oxycodone and marijuana.
2. What does high-cutoff OPI/2000 mean? It means the morphine and opiate panel uses a manufacturer-listed preliminary screening cutoff of 2,000 ng/mL.
3. Why are BUP, MTD, OPI and OXY tested separately? Buprenorphine, methadone and oxycodone may not be detected with equal sensitivity by a traditional opiate panel. Dedicated strips provide targeted preliminary screening.
4. Does this cup include a dedicated MDMA panel? Yes. It includes a separate MDMA panel at the manufacturer-listed 500 ng/mL screening cutoff.
5. What does the temperature strip verify? The strip measures specimen temperature shortly after collection and helps identify samples outside the expected temperature range. It does not independently prove specimen authenticity.
6. Is a presumptive positive result final? No. Presumptive positive results should be confirmed using an appropriate laboratory method before clinical, employment, treatment or legal decisions are made.
Ten Drug Panels. MDMA and Buprenorphine Screening. High-Cutoff OPI/2000. Simplify preliminary urine drug screening with a self-contained 120 mL cup designed for secure collection, rapid results and broad opioid-related coverage.
Order 10-Panel Drug Test Cups Today